Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Abraham Weizman |
| Publication date | January 1, 2004 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |